• OPEN AN ACCOUNT
Indian Indices
Sensex
71,523.20 -1,115.50
( -1.54%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,456.95 -84.74
(-0.80%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
163.1433353
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FREDUN
54.93
2441.1
EPS(TTM)
Face Value()
Div & Yield %
26.87
10
0.02
 

Diligent Industries standalone net profit declines 20.45% in the March 2026 quarter
Jun 01,2026
Net profit of Diligent Industries declined 20.45% to Rs 0.35 crore in the quarter ended March 2026 as against Rs 0.44 crore during the previous quarter ended March 2025. Sales declined 42.60% to Rs 29.85 crore in the quarter ended March 2026 as against Rs 52.00 crore during the previous quarter ended March 2025.

For the full year,net profit remain constant at Rs 2.52 crore in the year ended March 2026 and also during the previous year ended March 2025. Sales rose 6.54% to Rs 152.95 crore in the year ended March 2026 as against Rs 143.56 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales29.8552.00 -43 152.95143.56 7
OPM %5.463.29 -4.965.33 -
PBDT1.141.21 -6 5.235.06 3
PBT0.710.71 0 3.493.49 0
NP0.350.44 -20 2.522.52 0